PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,202,981 | -44.9% | 263,830 | -12.2% | 0.00% | -50.0% |
| Q2 2023 | $3,997,049 | +50.5% | 300,530 | +31.1% | 0.00% | +100.0% |
| Q1 2023 | $2,655,294 | +35.6% | 229,300 | -4.2% | 0.00% | 0.0% |
| Q4 2022 | $1,957,474 | +38.3% | 239,300 | -1.8% | 0.00% | 0.0% |
| Q3 2022 | $1,415,000 | +31.4% | 243,700 | 0.0% | 0.00% | – |
| Q2 2022 | $1,077,000 | -51.7% | 243,700 | -0.4% | 0.00% | -100.0% |
| Q1 2022 | $2,228,000 | -55.4% | 244,800 | +0.2% | 0.00% | -50.0% |
| Q4 2021 | $4,996,000 | -19.9% | 244,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,239,000 | -27.4% | 244,200 | -0.6% | 0.00% | -33.3% |
| Q2 2021 | $8,589,000 | +7.8% | 245,600 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $7,968,000 | +19.7% | 239,200 | -6.7% | 0.00% | 0.0% |
| Q4 2020 | $6,654,000 | +198.4% | 256,500 | +13.5% | 0.00% | +200.0% |
| Q3 2020 | $2,230,000 | +229.4% | 225,900 | +15.1% | 0.00% | – |
| Q2 2020 | $677,000 | +12.6% | 196,300 | 0.0% | 0.00% | – |
| Q1 2020 | $601,000 | -89.3% | 196,300 | -82.1% | 0.00% | -100.0% |
| Q4 2019 | $5,629,000 | +35.7% | 1,095,128 | +36.3% | 0.00% | 0.0% |
| Q3 2019 | $4,147,000 | -8.4% | 803,733 | +7.4% | 0.00% | 0.0% |
| Q2 2019 | $4,529,000 | +58.4% | 748,558 | +89.3% | 0.00% | +50.0% |
| Q1 2019 | $2,859,000 | -13.5% | 395,379 | -11.5% | 0.00% | 0.0% |
| Q4 2018 | $3,307,000 | +334.6% | 446,857 | +217.6% | 0.00% | – |
| Q3 2018 | $761,000 | +52.5% | 140,700 | 0.0% | 0.00% | – |
| Q2 2018 | $499,000 | +109.7% | 140,700 | +21.3% | 0.00% | – |
| Q1 2018 | $238,000 | -12.5% | 116,000 | +12.6% | 0.00% | – |
| Q4 2017 | $272,000 | -49.7% | 103,000 | 0.0% | 0.00% | – |
| Q3 2017 | $541,000 | +32.9% | 103,000 | -9.8% | 0.00% | – |
| Q2 2017 | $407,000 | +0.2% | 114,200 | +45.5% | 0.00% | – |
| Q1 2017 | $406,000 | +36.2% | 78,500 | 0.0% | 0.00% | – |
| Q4 2016 | $298,000 | -61.2% | 78,500 | -8.5% | 0.00% | -100.0% |
| Q3 2016 | $769,000 | +27.3% | 85,800 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $604,000 | -15.0% | 85,800 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $711,000 | -47.8% | 83,600 | -19.5% | 0.00% | 0.0% |
| Q4 2015 | $1,363,000 | +289.4% | 103,800 | +8.5% | 0.00% | – |
| Q3 2015 | $350,000 | -36.5% | 95,700 | 0.0% | 0.00% | – |
| Q2 2015 | $551,000 | +3.8% | 95,700 | +5.3% | 0.00% | – |
| Q1 2015 | $531,000 | -29.9% | 90,900 | -5.8% | 0.00% | -100.0% |
| Q4 2014 | $757,000 | +100.3% | 96,500 | +25.5% | 0.00% | – |
| Q3 2014 | $378,000 | -20.4% | 76,900 | 0.0% | 0.00% | – |
| Q2 2014 | $475,000 | +13.1% | 76,900 | -2.1% | 0.00% | – |
| Q1 2014 | $420,000 | +2.2% | 78,522 | 0.0% | 0.00% | – |
| Q4 2013 | $411,000 | -15.6% | 78,522 | -10.9% | 0.00% | – |
| Q3 2013 | $487,000 | +20.8% | 88,122 | -44.9% | 0.00% | – |
| Q2 2013 | $403,000 | – | 160,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |